AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin
- PMID: 16891465
- DOI: 10.1158/1535-7163.MCT-05-0361
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin
Abstract
AGRO100, also known as AS1411, is an experimental anticancer drug that recently entered human clinical trials. It is a member of a novel class of antiproliferative agents known as G-rich oligonucleotides (GRO), which are non-antisense, guanosine-rich phosphodiester oligodeoxynucleotides that form stable G-quadruplex structures. The biological activity of GROs results from their binding to specific cellular proteins as aptamers. One important target protein of GROs has been previously identified as nucleolin, a multifunctional protein expressed at high levels by cancer cells. Here, we report that AGRO100 also associates with nuclear factor-kappaB (NF-kappaB) essential modulator (NEMO), which is a regulatory subunit of the inhibitor of kappaB (IkappaB) kinase (IKK) complex, and also called IKKgamma. In the classic NF-kappaB pathway, the IKK complex is required for phosphorylation of IkappaBalpha and subsequent activation of the transcription factor NF-kappaB. We found that treatment of cancer cells with AGRO100 inhibits IKK activity and reduces phosphorylation of IkappaBalpha in response to tumor necrosis factor-alpha stimulation. Using a reporter gene assay, we showed that AGRO100 blocks both tumor necrosis factor-alpha-induced and constitutive NF-kappaB activity in human cancer cell lines derived from cervical, prostate, breast, and lung carcinomas. In addition, we showed that, in AGRO100-treated cancer cells, NEMO is coprecipitated by nucleolin, indicating that both proteins are present in the same complex. Our studies suggest that abrogation of NF-kappaB activity may contribute to the anticancer effects of AGRO100 and that nucleolin may play a previously unknown role in regulating the NF-kappaB pathway.
Similar articles
-
Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.BMC Genomics. 2010 Dec 2;11 Suppl 4(Suppl 4):S25. doi: 10.1186/1471-2164-11-S4-S25. BMC Genomics. 2010. PMID: 21143809 Free PMC article.
-
ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.J Biol Chem. 2006 Jul 7;281(27):18482-8. doi: 10.1074/jbc.M601502200. Epub 2006 May 9. J Biol Chem. 2006. PMID: 16684768
-
Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.Biochem Pharmacol. 2005 Nov 15;70(10):1443-57. doi: 10.1016/j.bcp.2005.08.011. Epub 2005 Sep 21. Biochem Pharmacol. 2005. PMID: 16181613
-
Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.Biochem Biophys Res Commun. 2010 Jun 4;396(3):585-9. doi: 10.1016/j.bbrc.2010.05.012. Epub 2010 May 10. Biochem Biophys Res Commun. 2010. PMID: 20457134 Review.
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
Cited by
-
Antiproliferative Effects of the Aptamer d(GGGT)4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells.Int J Mol Sci. 2022 May 25;23(11):5952. doi: 10.3390/ijms23115952. Int J Mol Sci. 2022. PMID: 35682635 Free PMC article.
-
Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription.Nucleic Acids Res. 2015 Oct 15;43(18):8884-97. doi: 10.1093/nar/gkv897. Epub 2015 Sep 9. Nucleic Acids Res. 2015. PMID: 26354862 Free PMC article.
-
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma.Cancers (Basel). 2022 Oct 14;14(20):5048. doi: 10.3390/cancers14205048. Cancers (Basel). 2022. PMID: 36291832 Free PMC article.
-
Solution structure of the RBD1,2 domains from human nucleolin.J Biomol NMR. 2010 May;47(1):79-83. doi: 10.1007/s10858-010-9412-1. Epub 2010 Apr 8. J Biomol NMR. 2010. PMID: 20376532 No abstract available.
-
Aptamers as therapeutics.Nat Rev Drug Discov. 2010 Jul;9(7):537-50. doi: 10.1038/nrd3141. Nat Rev Drug Discov. 2010. PMID: 20592747 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous